Tag: RegeneRX

RegeneRx receives “decision to grant” European patent for treatment of peripheral...

RegeneRx Biopharmaceuticals has announced that the European Patent Office has issued a decision to grant a new patent for treating patients with peripheral neuropathy...

RegeneRX receives Canadian patent for treating neurological injury and damage

RegeneRx Biopharmaceuticals has announced that the Canadian Patent Office has issued a Notice of Allowance for Thymosin beta 4 (Tβ4) for use in the treatment...